Team

Spirify Executive Team

• Sigal Kremer-Tal, MD

  CEO; Physician entrepreneur, track record in early-stage development. J&J, Novartis, Mount Sinai School of Medicine, NY. MD from Hebrew University.
• Irving Wainer, PhD

  CSO; PI at NIA/NIH. US FDA, Prof. Oncology McGill University, Prof. Pharmacology George-town University; Cornell University, St. Jude’s Children’s Research Hospital
• Roni Appel, LLB, MBA

  COO, legal, financial, background. Investor, private equity, venture capital, financing, M&A. Co-Founder/CEO Advaxis, Co-Founder/CEO of Anima Cell.
• Joseph V.Pergolizzi, Jr, MD

  Board member, Advisor. COO at NEMA Research. MD (highest honors) from Ross University School of Medicine, Georgetown University School of Medicine, Johns Hopkins School of Medicine.
• Alexander Kraus, PhD

  CBO, preclinical / clinical R&D, portfolio, business development strategy, commercial valuation. Grünenthal, Aquestive Therapeutics. AK Pharma Consulting, PhD Chemistry Univ. Cologne.

Spirify Advisory Board

• Charles Argoff, MD

  Professor at Albany Medical Center, Albany/NY; pain management, chronic headaches and neuropathic pain. Board Certified Neurology and Pain Medicine. Development of neuropathic pain guidelines.
• Eugene R. Viscusi, MD Director Acute Pain Management

  Service Dept. Anesthesiology Thomas Jefferson Univ. Development of new pain management techniques, novel agents and delivery systems for pain.
• Herman Wolosker, MD, PhD

  Professor of Neurosciences at Technion-Israel Institute of Technology. 20+ years of preclinical research expertise on D-Serine as a neurotransmitter and mechanisms of D-Serine regulation in the CNS.
• Christopher Gharibo, MD

  Assist. Prof. Anesthesiology at NYU School of Medicine, Medical Dir. Bellevue Pain Treatment Center at Bellevue Hospital Center in NYC.
• Thomas Christoph, PhD

  Specialized in pharmacology of anti-inflammatory and analgesic drugs. Hafslund, Nycomed, Grünenthal. Special focus on the translational value proposition of pre-clinical data.
• Michael A. Rogawski, MD, PhD

  Professor of Neurology and Pharmacology at the Center for Neuroscience at the University of California, Davis. Former chief of the Epilepsy Research Section at NIH/NINDS.